GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Accounts Payable

FibroBiologics (FibroBiologics) Accounts Payable : $0.81 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Accounts Payable?

FibroBiologics's Accounts Payable for the quarter that ended in Mar. 2024 was $0.81 Mil.

FibroBiologics's quarterly Accounts Payable increased from Sep. 2023 ($0.82 Mil) to Dec. 2023 ($1.44 Mil) but then declined from Dec. 2023 ($1.44 Mil) to Mar. 2024 ($0.81 Mil).

FibroBiologics's annual Accounts Payable increased from Dec. 2021 ($0.23 Mil) to Dec. 2022 ($0.76 Mil) and increased from Dec. 2022 ($0.76 Mil) to Dec. 2023 ($1.44 Mil).


FibroBiologics Accounts Payable Historical Data

The historical data trend for FibroBiologics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Accounts Payable Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Accounts Payable
0.23 0.76 1.44

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only - 0.60 0.82 1.44 0.81

FibroBiologics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


FibroBiologics Accounts Payable Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines